Skip to main content
Norman Sharpless, MD, Oncology, Bethesda, MD

NormanESharplessMD

Oncology Bethesda, MD

Director, NCI

Dr. Sharpless is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sharpless' full profile

Already have an account?

  • Office

    9609 Medical Center Drive
    Building 9609 MSC 9760
    Bethesda, MD 20892
    Phone+1 240-781-3300

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1996 - 2000
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1993 - 1996
  • University of North Carolina at Chapel Hill School of Medicine
    University of North Carolina at Chapel Hill School of MedicineClass of 1993

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2002 - 2018

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2008

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Special Session with the National Cancer Institute Director 
    60th American Society of Hematology Annual Meeting - 12/1/2018

Press Mentions

  • Karius Secures $100M to Expand Non-Invasive Pathogen Blood Test
    Karius Secures $100M to Expand Non-Invasive Pathogen Blood TestFebruary 5th, 2024
  • Katie Couric’s Breast Cancer Diagnosis Highlights the Importance of Screenings
    Katie Couric’s Breast Cancer Diagnosis Highlights the Importance of ScreeningsOctober 5th, 2022
  • Americans Are Reckoning with Repercussions of Missed Cancer Screenings
    Americans Are Reckoning with Repercussions of Missed Cancer ScreeningsJune 13th, 2022
  • Join now to see all

Grant Support

  • In Vivo Murine Models Of Metastasis For Therapeutic TestingNational Cancer Institute2012
  • UNC Oncology Clinical Translational Research Training ProgramNational Cancer Institute2011
  • Murine &Human In Vivo Models Of Melanoma FormationNational Institute Of Environmental Health Sciences2007–2011
  • The Role Of P16INK4A In Mammalian AgingNational Institute On Aging2004–2011
  • Melanoma In P16INK4A And P19ARF Deficient MiceNational Cancer Institute2002–2006
  • Melanoma In P16INK4A And P19ARF Deficient MiceNational Cancer Institute2002

Professional Memberships

Other Languages

  • Spanish